Menopause
Research: Low-dose estrogen patch viable short-term option for menopausal women
Published in Women's Health Weekly, May 20th, 2004
Low-dose transdermal hormone therapy (HT) remains a viable short-term alternative for women to treat debilitating menopausal symptoms, offer lipid protection, and preserve bone health, despite the negative news about oral HT effects from the Women's Health Initiative (WHI), according to a recent review of peer-reviewed medical studies by Mary Jane Minkin, MD, of Yale University School of Medicine.
Her findings were reported in the April issue of the Journal of Reproductive Medicine.
"There is a lot to consider when interpreting the WHI results. The fact is that millions of women still suffer from the potentially devastating symptoms of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Activism
March highlights global impact of U.S. reproductive health policies - Endocrinology
Testosterone replacement improves muscle strength, function in HIV+ women - Mammography
Women use different strategies to cope with the pain of mammograms - Obstetrics
Antenatal factors associated with maternal infection hamper infant neurology - Urinary Incontinence
Combinations of behavioral and drug therapy help patients with incontinence - Abortion
Utah hospital won't terminate pregnancies in cases of fatal fetal deformity - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
